Involvement of MicroRNA-198 overexpression in the poor prognosis of esophageal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5073-5076

  Qi, Bo ^a   Yao, Wen Jian ^a   Zhao, Bao Sheng ^a   Qin, Xiu Guang ^a   Wang, Yi ^a   Wang, Wen Ju ^a   Wang, Tian Yun ^b   Liu, Shang Guo ^a   Li, Han Chen ^a  

^a The Third Hospital of Xinxiang Medical University   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; MicroRNA 198; Prognosis

Indexed keywords

MICRORNA; MIRN198 MICRORNA, HUMAN; TUMOR MARKER;

AGED; DISEASE FREE SURVIVAL; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TIME; TUMOR VOLUME;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84887569019     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5073     Document Type: Article

References (18)

1. He B, Pan Y, Cho WC, et al (2012). The Association between Four Genetic Variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and Cancer Risk: Evidence from Published Studies. PLoS One, 7, e49032.
2. Hobert O (2008). Gene regulation by transcription factors and microRNAs. Science, 319, 1785-6.
3. Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54.
4. Liang M, Liu Y, Mladinov D, et al (2009). MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol, 297, F553-8.
5. Lin RJ, Xiao DW, Liao LD, et al (2012). MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol, 105, 175-82.
6. Matsushima K, Isomoto H, Kohno S, Nakao K (2010). MicroRNAs and esophageal squamous cell carcinoma. Digestion, 82, 138-44.
7. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
8. Schultz NA, Werner J, Willenbrock H, et al (2012). MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol, 25, 1609-22.
9. Tan S, Li R, Ding K, Lobie PE, Zhu T (2011). miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett, 585, 2229-34.
10. Varnholt H, Drebber U, Schulze F, et al (2008). MicroRNA Gene Expression Profile of Hepatitis C Virus-Associated Hepatocellular Carcinoma. Hepatology, 47, 1223-32.
11. Wong TS, Liu XB, Wong BY, et al (2008). MaturemiR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res, 14, 2588-92.
12. Xu X, Chen Z, Zhao X, et al (2012). MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem Biophys Res Commun, 421, 640-5.
13. Yang M, Liu R, Sheng J, et al (2013). Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol Rep, 29, 169-76.
14. Ye L, Li S, Ye D, et al (2013). Livin expression may be regulated by miR-198 in human prostate cancer cell lines. Eur J Cancer, 49, 734-40.
15. Yu Z, Baserga R, Chen L, et al (2010). microRNA, cell cycle, and human breast cancer. Am J Pathol, 176, 1058-64.
16. Zhao JJ, Yang J, Lin J, et al (2009). Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst, 25, 13-20.
17. Zhou ZQ, Cao WH, Xie JJ, et al (2009). Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer, 9, 291.
18. Zoon CK, Starker EQ, Wilson AM, et al (2009). Current molecular diagnostics of breast cancer and the potential incorporation of microRNA. Expert Rev Mol Diagn, 9, 455-67.